Zhi Hong, Brii Biosciences CEO
Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request
Brii Biosciences said it will stop manufacturing its Covid-19 antibody combination, sold in China, and is working to withdraw its emergency use authorization request in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.